Loading...
Market
How many new studies on aspirin's cancer-preventive properties will be published by December 31, 2024?
2
Resolution / Starting Odds
Less than 5 • 25%
5 to 10 • 25%
10 to 15 • 25%
More than 15 • 25%
PubMed or other scientific publication databases
Story
Harvard Study: Daily Aspirin Use Reduces Colorectal Cancer Risk by a Third
Aug 1, 2024, 03:15 PM
A major study has found that regular use of aspirin can significantly reduce the risk of developing colorectal cancer, even among individuals with unhealthy lifestyles. The study, conducted by researchers at Harvard and MassGenBrigham and published in JAMA Oncology, indicates that taking aspirin daily may reduce the risk of colon cancer by up to a third. This protective effect is believed to be due to aspirin's ability to block polyps, which are precursors to cancer. The findings offer hope for preventing colorectal cancer, which is a growing epidemic.
View original story
Similar markets
0-2 trials • 25%
3-5 trials • 25%
6-8 trials • 25%
More than 8 trials • 25%
0-2 studies • 25%
3-5 studies • 25%
6-8 studies • 25%
More than 8 studies • 25%
Yes • 50%
No • 50%
0 • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
More than 10 studies • 25%
5-10 studies • 25%
1-4 studies • 25%
No studies • 25%
0-5 trials • 25%
6-10 trials • 25%
11-15 trials • 25%
More than 15 trials • 25%
Less than 50 • 25%
50 to 100 • 25%
101 to 200 • 25%
More than 200 • 25%
0-10 • 25%
11-20 • 25%
21-30 • 25%
31 or more • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
0-5 trials • 25%
6-10 trials • 25%
11-15 trials • 25%
More than 15 trials • 25%
0-5 trials • 25%
6-10 trials • 25%
11-15 trials • 25%
More than 15 trials • 25%